Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of neuroactive agents and central nervous system modulators. Its structure supports the creation of bioactive molecules due to the presence of both the trifluoroacetamide group and the bromophenethyl moiety, which can enhance binding selectivity and metabolic stability. Commonly employed in medicinal chemistry for constructing peptidomimetics and enzyme inhibitors. Also utilized in research settings to develop novel analogs for structure-activity relationship (SAR) studies.